The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Matrix Metalloproteinases: A Review
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., & Engler, J. A. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040020401 · Cited by 2,970
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,551
Self-citationMolecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5
Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., & Quaranta, V. (1997) · Science · doi:10.1126/science.277.5323.225 · Cited by 1,221 · cited 1×
“For example, cleavage of laminin-5 (a component of the ECM) by MT1-MMP and MMP-2 promotes migration of cells (Giannelli et al., 1997; Koshikawa et al., 2000).”
BackgroundA novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C., & Chambon, P. (1990) · Nature · doi:10.1038/348699a0 · Cited by 1,131
Proteolytic remodeling of extracellular matrix
Birkedal-Hansen, H. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80116-2 · Cited by 1,074
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988 · cited 1×
“Batimastat produced a 49 per cent reduction in angiogenesis in the prevention trial, an 83 per cent reduction in tumor burden in the intervention trial, but had no e ect on large, invasive tumors (Bergers et al., 1999).”
BackgroundOhuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., & Okada, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2446 · Cited by 938 · cited 1×
“MT1-MMP is also capable of hydrolyzing ®brillar collagen and digesting vitronectin, laminin, ®bronectin, enactin (d'Ortho et al., 1997; Ohuchi et al., 1997; Pei and Weiss, 1996) ®brinogen, and ®brin (Hiraoka et al., 1998).”
BackgroundMatrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Stetler-Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 842
Biswas, C., Zhang, Y., DeCastro, R., Guo, H., Nakamura, T., Kataoka, H., & Nabeshima, K. (1995) · PubMed · Cited by 716
Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins
Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., & Weiss, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81768-7 · Cited by 712
Tumor invasion and metastasis: an imbalance of positive and negative regulation.
Liotta, L. A., & Stetler‐Stevenson, W. G. (1991) · PubMed · Cited by 705
Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., & Tryggvason, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060037197 · Cited by 666
Matrix metalloproteinases in tumour invasion and metastasis
Curran, S., & Murray, G. I. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199911)189:3<300::aid-path456>3.0.co;2-c · Cited by 661
Role of Cell Surface Metalloprotease Mt1-Mmp in Epithelial Cell Migration over Laminin-5
Koshikawa, N., Giannelli, G., Cirulli, V., Miyazaki, K., & Quaranta, V. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.3.615 · Cited by 655
Matrix metalloproteinases: multifunctional contributors to tumor progression
McCawley, L. J., & Matrisian, L. M. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01686-5 · Cited by 643
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-R¨th, F.-X., Maskos, K., Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N., Nagase, H., Brew, K., Bourenkov, G. P., et al. (1997) · Nature · doi:10.1038/37995 · Cited by 619 · cited 1×
“…compounds have been designed which combine backbone features (P1, P1', P2', p53' regions) which favorably interact with the enzyme subsites (S1, S1', S2', S3' pockets) and functionality capable of binding zinc (chelator) in the catalytic site (Gomis-Ruth et al., 1997; Grams et al., 1995).”
BackgroundMatrix metalloproteinase inhibitors
Wojtowicz-Praga, S. M., Dickson, R. B., & Hawkins, M. J. (1997) · Investigational New Drugs · doi:10.1023/a:1005722729132 · Cited by 518
Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
Hayakawa, T., Yamashita, K., Ohuchi, E., & Shinagawa, A. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.9.2373 · Cited by 451
IMAI, K., HIRAMATSU, A., FUKUSHIMA, D., PIERSCHBACHER, M. D., & OKADA, Y. (1997) · Biochemical Journal · doi:10.1042/bj3220809 · Cited by 445
D'ortho, M., Will, H., Atkinson, S., Butler, G., Messent, A., Gavrilovic, J., Smith, B., Timpl, R., Zardi, L., & Murphy, G. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00751.x · Cited by 443
Nakahara, H., Howard, L., Thompson, E. W., Sato, H., Seiki, M., Yeh, Y., & Chen, W.-T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7959 · Cited by 425
Self-citationPowell, W. C., Fingleton, B., Wilson, C. L., Boothby, M., & Matrisian, L. M. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80113-x · Cited by 424
TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages
Sarén, P., Welgus, H. G., & Kovanen, P. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.4159 · Cited by 406
Guedez, L., Stetler-Stevenson, W. G., Wolff, L., Wang, J., Fukushima, P., Mansoor, A., & Stetler-Stevenson, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2881 · Cited by 397
Pozzi, A., Moberg, P. E., Miles, L. A., Wagner, S., Soloway, P., & Gardner, H. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040378497 · Cited by 395
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
Fang, J., Shing, Y., Wiederschain, D., Yan, L., Butterfield, C., Jackson, G., Harper, J., Tamvakopoulos, G., & Moses, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.3884 · Cited by 393
Pei, D., & Weiss, S. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.9135 · Cited by 388
Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic
Stetler-Stevenson, W. G., Hewitt, R., & Corcoran, M. (1996) · Seminars in Cancer Biology · doi:10.1006/scbi.1996.0020 · Cited by 335
Activity of type IV collagenases in benign and malignant breast disease
Davies, B., Miles, D., Happerfield, L., Naylor, M., Bobrow, L., Rubens, R., & Balkwill, F. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.207 · Cited by 323
Zucker, S., Mirza, H., Conner, C. E., Lorenz, A. F., Drews, M. H., Bahou, W. F., & Jesty, J. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980302)75:5<780::aid-ijc19>3.0.co;2-a · Cited by 270
Self-citationJohnson, L. L., Dyer, R., & Hupe, D. J. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80122-1 · Cited by 270
Gelatinase B–deficient Mice Are Resistant to Experimental Bullous Pemphigoid
Liu, Z., Michael Shipley, J., Vu, T. H., Zhou, X., Diaz, L. A., Werb, Z., & Senior, R. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.475 · Cited by 243
SHALINSKY, D. R., BREKKEN, J., ZOU, H., MCDERMOTT, C. D., FORSYTH, P., EDWARDS, D., MARGOSIAK, S., BENDER, S., TRUITT, G., WOOD, A., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07689.x · Cited by 239
Velasco, G., Pendás, A. M., Fueyo, A., Knäuper, V., Murphy, G., & López-Otı́n, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4570 · Cited by 234
Yu, W.-H., & Woessner, J. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4183 · Cited by 231
Parsons, S. L., Watson, S. A., Brown, P. D., Collins, H. M., & Steele, R. J. C. (1997) · British Journal of Surgery · doi:10.1002/bjs.1800840206 · Cited by 229
Crawford, H. C., & Matrisian, L. M. (1996) · Enzyme and Protein · doi:10.1159/000468614 · Cited by 195
Bacterial Exposure Induces and Activates Matrilysin in Mucosal Epithelial Cells
López-Boado, Y. S., Wilson, C. L., Hooper, L. V., Gordon, J. I., Hultgren, S. J., & Parks, W. C. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1305 · Cited by 179
Grams, F., Crimmin, M., Hinnes, L., Huxley, P., Pieper, M., Tschesche, H., & Bode, W. (1995) · Biochemistry · doi:10.1021/bi00043a007 · Cited by 168
Matrix metalloproteinases in inflammatory demyelination: Targets for treatment
Kieseier, B. C., Seifert, T., Giovannoni, G., & Hartung, H.-P. (1999) · Neurology · doi:10.1212/wnl.53.1.20 · Cited by 167
Montgomery, A. M. P., Mueller, B. M., Reisfeld, R., Taylor, S. M., & DeClerck, Y. A. (1994) · PubMed · Cited by 166
Extracellular Matrix-Driven Matrix Metalloproteinase Production in Endothelial Cells
Haas, T. L., & Madri, J. A. (1999) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(99)00014-6 · Cited by 164
Membrane associated matrix metalloproteinases in metastasis
Ellerbroek, S. M., & Stack, M. S. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199911)21:11<940::aid-bies6>3.0.co;2-j · Cited by 160
Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.
Lehti, K., Valtanen, H., Wickström, S., Lohi, J., & Keski-Oja, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910220199 · Cited by 144
Polette, M., Gilles, C., Marchand, V., Lorenzato, M., Toole, B. P., Tournier, J., Zucker, S., & Birembaut, P. L. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500508 · Cited by 142
Self-citationHigh Affinity Binding of Latent Matrix Metalloproteinase-9 to the α2(IV) Chain of Collagen IV
Olson, M. W., Tóth, M., Gervasi, D. C., Sado, Y., Ninomiya, Y., & Fridman, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10672 · Cited by 139
Protease inhibitors: Role and potential therapeutic use in human cancer
DeClerck, Y. A., & Imren, S. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00460-m · Cited by 135
Matrix metalloproteinase inhibitors 1998
Beckett, R. P., & Whittaker, M. A. (1998) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.8.3.259 · Cited by 133
Emerging roles for proteinases in cancer.
Noël, A., Gilles, C., Bajou, K., Devy, L., Kebers, F., Lewalle, J.-M., Maquoi, E., Munaut, C., Remacle, A. G., & Foidart, J. (1997) · PubMed · Cited by 121
BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity.
Gatto, C., Rieppi, M., Borsotti, P., Innocenti, S., Ceruti, R., Drudis, T., Scanziani, E., Casazza, A. M., Taraboletti, G., & Giavazzi, R. (1999) · PubMed · Cited by 107
Matrix Metalloproteinases in Tissue Repair
Parks, W. C., Sudbeck, B. D., Doyle, G. R., & Saariahlo-Kere, U. K. (1998) · Elsevier eBooks · doi:10.1016/b978-012545090-4/50012-4 · Cited by 97
Building a Market Economy in Poland
Sachs, J. (1992) · Scientific American · doi:10.1038/scientificamerican0392-34 · Cited by 60
Matrix Metalloproteinase Inhibitors
Brown, P. D. N., & Whittaker, M. A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-453-5_13 · Cited by 5
Cited by
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Compensation mechanism in tumor cell migration
Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U. H., Deryugina, E. I., Strongin, A. Y., Bröcker, E.-B., & Friedl, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209006 · Cited by 1,391
Metadata
- Authors
- Zucker, S., Cao, J., & Chen, W.-T.
- Venue
- Oncogene
- Published
- 2000-12-27
- Volume
- 19
- Issue
- 56
- Pages
- 6642-6650
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2102884576
- Cited by
- 550
- References
- 61
- FWCI
- 12.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.